Saudi pharma market crucial to country’s Vision 203025 Sep 2019
Plan in the kingdom is to raise the percentage of total pharmaceutical production to 40% from the current 20%.
The importance of Saudi Arabia’s pharmaceutical industry in the delivery of the country’s 2030 Vision was highlighted at CPhI Middle East & Africa.
During a presentation by Dr Faisal BinDail, Chairman of the National Committee for Pharmaceutical Industries, titled Delivering Saudi Arabia’s Vision 2030, a range of topics related to the pharmaceutical industry were discussed, including incentives for stimulating local manufacturing and the opportunities the emerging contract manufacturing sector present.
Dr BinDail said: “In the context of Saudi Arabia, pharma manufacturing holds an important position in achieving the Kingdom’s Vision 2030. The regulatory body, local industry players, global companies have realised the importance of this initiative and are working towards strengthening localised pharmaceutical manufacturing. Part of the transformation plan in the kingdom is to raise the percentage of total pharmaceutical production to 40% from the current 20%. The Government is supportive, local companies are gearing up and the regulatory body is encouraging, facilitating and providing incentives – thereby encouraging global companies to take advantage of this opportunity.
“Moreover, there is an enthusiasm among the local players to raise their standards and provide quality affordable medicines. Saudi Arabia is one of the few countries to adopt track and trace system to curb the menace of counterfeit.”
Saudi Arabia is the largest pharmaceutical market in the MENA region worth US$7.5 billion dollars and is expected to grow at a CAGR of around 5.5%.
“The market is dominated by branded products, as there is a preference for brands locally, but at the same time there is an opportunity for generics as well to expand. Around 20% of the pharma market is locally manufactured, while 80% is still imported from different countries, from the US, Europe, and different parts of the world, this is in brief how the pharmaceutical market in Saudi Arabia currently looks like,” added Dr BinDail.
Funding to accelerate delivery of Univercells' vaccine portfolio
11 Oct 2019
European financing to support Univercells’ R&D investments to develop four essential and undersupplied global health vaccines to be produced at affordable prices, high quality and large volumes.Read more
Industrial-scale manufacture of therapeutic exosomes
10 Oct 2019
Coordinated purification process development service accelerates progress to clinical trials, and scale-up manufacturing.Read more
Janssen opens new biomanufacturing building in Ireland
8 Oct 2019
Expansion creates 200 new full-time jobs and increases the company’s production capacity by an additional 19,100 m2.Read more
BASF and Biomillenia join forces in microbiome research to promote healthy skin
7 Oct 2019
Research aims to identify novel dermocosmetic active ingredients via unique microbiome-on-a-chip technology.Read more
Allergan expands Refresh eye treatment portfolio
7 Oct 2019
A trifecta of relief formulated with HydroCell technology offers new artificial tear options for patients suffering from eye dryness.Read more
BASF strengthens biotechnology footprint to enter natural F&F ingredients market
3 Oct 2019
Market entrance with biotech-based natural vanillin, valencene and nootkatone.Read more
Unidose device approved for Tosymra sumatriptan spray
3 Oct 2019
Provides migraine sufferers with a convenient, patient-friendly delivery approach.Read more
One-stop-platform for plant-based nutraceuticals
2 Oct 2019
In 2020, nutra brands will look to ensure they have plant-based options across all product classes with many actively looking to move entire portfolios plant-based.Read more
BASF's new bioactive ingredient the wellness elixir for healthy skin
1 Oct 2019
The active ingredient is a 100% natural extract from the chaga mushroom, obtained using an innovative eco-friendly technology: subcritical water extraction.Read more
Arctoris secures funding to advance novel robotic drug discovery platform
1 Oct 2019
Platform will enable scientists and biotechnology entrepreneurs worldwide to make discoveries faster and more efficiently,Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation